GlassScriptPhysician profile
Suresh Potluri
NPI 1871757708
$6,000.98
in general payments reported to CMS, 2019-2025
29 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,023 · 2020: $414 · 2021: $194 · 2022: $473 · 2023: $839 · 2024: $2,713 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,116 · Travel and Lodging: $1,617 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,116.40 |
| Travel and Lodging | $1,616.85 |
| Education | $164.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,126.86 | 2024-2025 | Interstim |
| Astellas Pharma US INC | $851.27 | 2019-2024 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $649.65 | 2019-2024 | Lithovue |
| Janssen Biotech, INC. | $433.26 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Axonics, INC. | $365.25 | 2022-2023 | Axonics |
| Janssen Scientific Affairs, LLC | $208.25 | 2023-2025 | Erleada, Pipeline |
| Pfizer INC. | $203.68 | 2019-2024 | |
| Philips North America LLC | $170.07 | 2021 | |
| Conmed Corporation | $163.14 | 2024 | Airseal |
| Intuitive Surgical, INC. | $142.69 | 2023-2025 | Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $120.56 | 2023-2024 | Orgovyx |
| Allergan, INC. | $80.05 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $60.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $49.29 | 2020-2023 | Lynparza |
| Urogen Pharma, INC. | $43.42 | 2023 | Jelmyto |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $40.89 | 2021-2022 | |
| Abbvie INC. | $36.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.31 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $33.20 | 2023 | Pylarify |
| Dentsply Ih Ab | $28.75 | 2023 | Lofric |
| Foundation Medicine, INC. | $27.44 | 2023 | Foundationone Liquid Cdx |
| Coloplast Corp | $20.05 | 2024 | |
| Olympus America INC. | $18.63 | 2019 | |
| Endo Pharmaceuticals INC. | $16.76 | 2020 | |
| Cook Medical LLC | $15.90 | 2024 | Litho 150 |
| Procept Biorobotics Corporation | $15.82 | 2019 | |
| Acell, INC. | $15.72 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.15 | 2019 | |
| Merck Sharp & Dohme LLC | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suresh Potluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.